IL10 and neoplasm: These HMGB1-carrying TRAPs then directly educate B cells to become IL-10-producing immunosuppressive cells, which in turn suppress the activity of both CD4+ and CD8+ T cells, creating a potent barrier to anti-tumor immunity and fostering an environment conducive to therapy resistance [111].